The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage organic process. Preliminary routes focused on protein portion coupling, utilizing solid-phase https://jadazsmo587703.digiblogbox.com/65106438/creation-and-study-uses-of-retatrutide